Just after 12 o’clock today, the creditors of medical diagnostics firm HiberGene Diagnostics logged on to a virtual meeting to liquidate the company. Even before the meeting started, most participants knew it would be a testy affair. The once-promising company had raised more than €15 million from investors and had 13 products in its armoury. However, undone by an inability to convert products into enough revenue and ongoing shareholder strife, the directors opted to call in the liquidator. As Francesca has previously reported, management have blamed dissenters for leaking confidential information to the media, something they say damaged HiberGene’s reputation…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .